1ap4 image
Deposition Date 1997-07-24
Release Date 1998-07-15
Last Version Date 2024-05-22
Entry Detail
PDB ID:
1AP4
Keywords:
Title:
REGULATORY DOMAIN OF HUMAN CARDIAC TROPONIN C IN THE CALCIUM-SATURATED STATE, NMR, 40 STRUCTURES
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
43
Conformers Submitted:
40
Selection Criteria:
LEAST RESTRAINT VIOLATION
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:CARDIAC N-TROPONIN C
Gene (Uniprot):TNNC1
Chain IDs:A
Chain Length:89
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Calcium-induced structural transition in the regulatory domain of human cardiac troponin C.
Biochemistry 36 12138 12146 (1997)
PMID: 9315850 DOI: 10.1021/bi971223d

Abstact

While calcium binding to troponin C (TnC) triggers the contraction of both skeletal and cardiac muscle, there is clear evidence that different mechanisms may be involved. For example, activation of heart myofilaments occurs with binding to a single regulatory site on TnC, whereas activation of fast skeletal myofilaments occurs with binding to two regulatory sites. The physiological difference between activation of cardiac and skeletal myofilaments is not understood at the molecular level due to a lack of structural details for the response of cardiac TnC to calcium. We determined the solution structures of the apo and calcium-saturated regulatory domain of human cardiac TnC by using multinuclear, multidimensional nuclear magnetic resonance spectroscopy. The structure of apo human cardiac TnC is very similar to that of apo turkey skeletal TnC even though there are critical amino acid substitutions in site I. In contrast to the case with the skeletal protein, the calcium-induced conformational transition in the cardiac regulatory domain does not involve an "opening" of the regulatory domain, and the concomitant exposure of a substantial hydrophobic surface area. This result has important implications with regard to potential unique aspects of the interaction of cardiac TnC with cardiac troponin I and of modification of cardiac myofilament regulation by calcium-sensitizer drugs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures